Pfizer Will Seek Out More R&D Opportunities in Korea
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Pfizer Korea will seek more opportunities for R&D partnerships in Korea as it tries to develop treatments for Asia-prevalent liver and stomach cancers
You may also be interested in...
MNC Products Retain Dominance In Korea As Local Generics Face Challenges
SEOUL - Multinational company products covered by South Korea's national medical insurance system were the most prescribed last year, according to recent government data
MNC Products Retain Dominance In Korea As Local Generics Face Challenges
SEOUL - Multinational company products covered by South Korea's national medical insurance system were the most prescribed last year, according to recent government data
Pfizer Korea Builds Up Presence Further In Korea Through Merger With Wyeth Korea
SEOUL - With the Jan. 29 approval of South Korea's Fair Trade Commission, Pfizer swiftly integrated its operations with Wyeth Korea to become one entity Feb. 1